Drug price history · CMS NADAC read 11 November 2026
Generic
$0.128 per unit at the 2013 year-end survey (23 NDCs) and $0.023 at the 2026 survey (70 NDCs): −82%.
| Year-end survey | Median per unit | Lowest to highest | NDCs priced |
|---|---|---|---|
| 2013 (2013-12-25) | $0.128 | 23 | |
| 2014 (2014-12-31) | $0.118 | 25 | |
| 2015 (2015-12-30) | $0.107 | 19 | |
| 2016 (2016-12-28) | $0.096 | 23 | |
| 2017 (2017-12-27) | $0.060 | 28 | |
| 2018 (2018-12-26) | $0.056 | 31 | |
| 2019 (2019-12-25) | $0.056 | 40 | |
| 2020 (2020-12-30) | $0.038 | 47 | |
| 2021 (2021-12-29) | $0.034 | 52 | |
| 2022 (2022-12-28) | $0.032 | 54 | |
| 2023 (2023-12-27) | $0.032 | 50 | |
| 2024 (2024-12-25) | $0.026 | 59 | |
| 2025 (2025-12-31) | $0.025 | 67 | |
| 2026 (2026-11-11) | $0.023 | 70 |
Generic
$0.177 per unit at the 2013 year-end survey (23 NDCs) and $0.029 at the 2026 survey (69 NDCs): −84%.
| Year-end survey | Median per unit | Lowest to highest | NDCs priced |
|---|---|---|---|
| 2013 (2013-12-25) | $0.177 | 23 | |
| 2014 (2014-12-31) | $0.156 | 26 | |
| 2015 (2015-12-30) | $0.134 | 20 | |
| 2016 (2016-12-28) | $0.126 | 25 | |
| 2017 (2017-12-27) | $0.080 | 29 | |
| 2018 (2018-12-26) | $0.072 | 33 | |
| 2019 (2019-12-25) | $0.077 | 40 | |
| 2020 (2020-12-30) | $0.054 | 48 | |
| 2021 (2021-12-29) | $0.056 | 52 | |
| 2022 (2022-12-28) | $0.037 | 53 | |
| 2023 (2023-12-27) | $0.039 | 48 | |
| 2024 (2024-12-25) | $0.032 | 57 | |
| 2025 (2025-12-31) | $0.031 | 66 | |
| 2026 (2026-11-11) | $0.029 | 69 |
Generic
$0.175 per unit at the 2013 year-end survey (24 NDCs) and $0.037 at the 2026 survey (69 NDCs): −79%.
| Year-end survey | Median per unit | Lowest to highest | NDCs priced |
|---|---|---|---|
| 2013 (2013-12-25) | $0.175 | 24 | |
| 2014 (2014-12-31) | $0.155 | 27 | |
| 2015 (2015-12-30) | $0.142 | 22 | |
| 2016 (2016-12-28) | $0.134 | 24 | |
| 2017 (2017-12-27) | $0.096 | 28 | |
| 2018 (2018-12-26) | $0.103 | 34 | |
| 2019 (2019-12-25) | $0.091 | 43 | |
| 2020 (2020-12-30) | $0.079 | 48 | |
| 2021 (2021-12-29) | $0.064 | 52 | |
| 2022 (2022-12-28) | $0.067 | 54 | |
| 2023 (2023-12-27) | $0.058 | 48 | |
| 2024 (2024-12-25) | $0.047 | 57 | |
| 2025 (2025-12-31) | $0.042 | 66 | |
| 2026 (2026-11-11) | $0.037 | 69 |
Generic
$0.189 per unit at the 2013 year-end survey (21 NDCs) and $0.068 at the 2026 survey (67 NDCs): −64%.
| Year-end survey | Median per unit | Lowest to highest | NDCs priced |
|---|---|---|---|
| 2013 (2013-12-25) | $0.189 | 21 | |
| 2014 (2014-12-31) | $0.179 | 21 | |
| 2015 (2015-12-30) | $0.158 | 19 | |
| 2016 (2016-12-28) | $0.183 | 23 | |
| 2017 (2017-12-27) | $0.129 | 25 | |
| 2018 (2018-12-26) | $0.127 | 31 | |
| 2019 (2019-12-25) | $0.144 | 39 | |
| 2020 (2020-12-30) | $0.118 | 45 | |
| 2021 (2021-12-29) | $0.107 | 50 | |
| 2022 (2022-12-28) | $0.098 | 53 | |
| 2023 (2023-12-27) | $0.089 | 47 | |
| 2024 (2024-12-25) | $0.075 | 55 | |
| 2025 (2025-12-31) | $0.073 | 64 | |
| 2026 (2026-11-11) | $0.068 | 67 |
CMS National Average Drug Acquisition Cost, year-end surveys 2013 to 2026. A pharmacy acquisition cost, not a retail price. About NADAC.
The FDA Orange Book lists 20 generic makers as marketed in its largest dosage form for Atorvastatin, and the first generic approval is dated 30 November 2011. The acquisition costs above are what pharmacies pay across the NDCs priced; the Orange Book count is a separate record and this page does not say that more makers lowered a price. See each maker and the patents still listed on OmniRx.
Open it in the check to search another drug, or see the CMS pharmacy pricing page for what NADAC measures. These are pharmacy costs, not prices: for what people pay for Atorvastatin at the counter, see Atorvastatin prices and ways to pay less. For who makes the generic and which patents are listed, see the generic competition check for Atorvastatin on OmniRx. To check whether a drug is in shortage, see the FDA drug shortages page.
Compiled and checked by Vincent Wesley Couey (ORCID 0009-0005-6869-308X) from the CMS pharmacy pricing page, year-end surveys 2013 to 2026 (latest 11 November 2026).